Katherine Pollard’s expertise, success, and vision fueled her promotion to director of Gladstone’s Convergence Zone.
News and Highlights
A new biopharmaceutical company, Tenaya Therapeutics Inc., will build on discoveries in cardiovascular disease research made at the Gladstone Institutes, concentrating on regenerative medicine and drug discovery for heart failure.
Anatol Kreitzer was unanimously selected based on his experience training graduate students and his vision for the future.
Jennifer Doudna, PhD, was recognized for pioneering technology that transformed gene editing and revolutionized biomedical research.
Meredith Calvert shares how her family history and her passions for art and biology led her to a career in microscopy.
Yen-Sin Ang, PhD, a research scientist at the Gladstone Institutes, was awarded the Louis N. and Arnold M.
In a meeting of the minds, Gladstone hosted a national behavioral neuroscience symposium to share scientific breakthroughs and compare research methods.
The delayed antiviral immune response allows the virus to remain undetected in the vagina, which can increase the risk of fetal infection during pregnancy.
Behind the scenes at the Gladstone Institutes, there is a group of community leaders who understand that the search for cures must begin with deep biological knowledge.
Gladstone scientists discover how to control the cacophony of electrical activity in the brain, stopping seizures and reducing deficits related to Alzheimer’s disease.